During SOHO 2019 in Houston, US, the Lymphoma Hub was pleased to talk with Dr Kieron M. Dunleavy from The George Washington University, Washington, US, about the treatment of double-hit lymphoma. He discusses treatment strategies aimed at patients with MYC and BCL2/BCL6 rearrangements, including BCL2 inhibitors, CAR T-cells, and bispecific antibodies.
12 сен 2019